LAM
GILD icon

Lebenthal Asset Management’s Gilead Sciences GILD Stock Holding History

Lebenthal Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$3.46M Sell
50,888
-11,071
-18% -$778K 0.43% 71
2016
Q4 		$4.44M Buy
61,959
+1,110
+2% +$82.5K 0.57% 46
2016
Q3 		$4.81M Buy
60,849
+3,352
+6% +$272K 0.62% 41
2016
Q2 		$4.8M Buy
57,497
+42,928
+295% +$3.81M 0.62% 41
2016
Q1 		$1.34M Buy
+14,569
New +$1.31M 0.54% 45

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Lebenthal Asset Management's GILD Position: Q1 2017 in Review

Lebenthal Asset Management reduced its Gilead Sciences (GILD) stake by 18% in Q1 2017, selling an estimated $778K and leaving 50,888 shares worth $3.46M. The position accounts for 0.43% of the portfolio, ranked #71.

Lebenthal Asset Management first reported a position in GILD in Q1 2016 and has held it in 5 quarters since. The position peaked at $4.81M in Q3 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Lebenthal Asset Management held 50,888 shares of Gilead Sciences worth $3.46M as of Q1 2017.
  • Lebenthal Asset Management sold 11,071 Gilead Sciences shares in Q1 2017, an estimated $778K.
  • Gilead Sciences made up 0.43% of Lebenthal Asset Management's portfolio in Q1 2017, its #71 holding.
  • Lebenthal Asset Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 5 quarters since.
  • Lebenthal Asset Management's Gilead Sciences position peaked at $4.81M in Q3 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.